These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 2524529

  • 1. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W, Burdick G, Carl V, Lachmann PJ.
    J Immunol; 1989 Jun 15; 142(12):4366-71. PubMed ID: 2524529
    [Abstract] [Full Text] [Related]

  • 2. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL, Takahashi H, Rudick RA, Knutson DW.
    J Immunol; 1986 Mar 01; 136(5):1765-71. PubMed ID: 2936811
    [Abstract] [Full Text] [Related]

  • 3. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
    Daha MR, Gorter A, Leijh PJ, Klar N, van Es LA.
    Immunology; 1988 Jul 01; 64(3):375-9. PubMed ID: 2970428
    [Abstract] [Full Text] [Related]

  • 4. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML, Bankovich AJ, McElhenny JL, Taylor RP.
    Arthritis Rheum; 2000 Oct 01; 43(10):2265-75. PubMed ID: 11037886
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC, Wright E, Taylor RP.
    J Immunol; 1987 Dec 01; 139(11):3739-47. PubMed ID: 2960742
    [Abstract] [Full Text] [Related]

  • 6. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA, Ng YC, Paccaud JP, Walport MJ.
    Clin Exp Immunol; 1989 Mar 01; 75(3):329-35. PubMed ID: 2522842
    [Abstract] [Full Text] [Related]

  • 7. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP, Carpentier JL, Schifferli JA.
    Eur J Immunol; 1990 Feb 01; 20(2):283-9. PubMed ID: 2138082
    [Abstract] [Full Text] [Related]

  • 8. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA, Virella G.
    Clin Exp Immunol; 1986 Apr 01; 64(1):195-204. PubMed ID: 3731526
    [Abstract] [Full Text] [Related]

  • 9. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC, Schifferli JA, Walport MJ.
    Clin Exp Immunol; 1988 Mar 01; 71(3):481-5. PubMed ID: 2968204
    [Abstract] [Full Text] [Related]

  • 10. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M, Schifferli JA.
    Schweiz Med Wochenschr; 1993 Jan 23; 123(3):39-43. PubMed ID: 8426946
    [Abstract] [Full Text] [Related]

  • 11. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP, Pocanic F, Reist C, Wright EL.
    Clin Immunol Immunopathol; 1991 Nov 23; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [Abstract] [Full Text] [Related]

  • 12. A study of in vivo immune complex formation and clearance in man.
    Davies KA, Hird V, Stewart S, Sivolapenko GB, Jose P, Epenetos AA, Walport MJ.
    J Immunol; 1990 Jun 15; 144(12):4613-20. PubMed ID: 2141040
    [Abstract] [Full Text] [Related]

  • 13. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A.
    J Immunol; 1999 Nov 01; 163(9):5056-63. PubMed ID: 10528211
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
    Emlen W, Carl V, Burdick G.
    Clin Exp Immunol; 1992 Jul 01; 89(1):8-17. PubMed ID: 1385769
    [Abstract] [Full Text] [Related]

  • 15. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA, Ng YC, Estreicher J, Walport MJ.
    J Immunol; 1988 Feb 01; 140(3):899-904. PubMed ID: 2963069
    [Abstract] [Full Text] [Related]

  • 16. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.
    Seelen MA, Athanassiou P, Lynn WA, Norsworthy P, Walport MJ, Cohen J, Davies KA.
    Immunology; 1995 Apr 01; 84(4):653-61. PubMed ID: 7790040
    [Abstract] [Full Text] [Related]

  • 17. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J, Hed J, Stendahl O.
    Immunology; 1985 May 01; 55(1):97-103. PubMed ID: 3158597
    [Abstract] [Full Text] [Related]

  • 18. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC, Kimberly RP, Taylor RP.
    Eur J Immunol; 1992 Jun 01; 22(6):1333-9. PubMed ID: 1376254
    [Abstract] [Full Text] [Related]

  • 19. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
    Beynon HL, Davies KA, Haskard DO, Walport MJ.
    J Immunol; 1994 Oct 01; 153(7):3160-7. PubMed ID: 8089493
    [Abstract] [Full Text] [Related]

  • 20. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML, Waitumbi JN, Taylor RP.
    J Immunol; 2005 Mar 01; 174(5):3059-66. PubMed ID: 15728520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.